B

Brainsway Ltd
TASE:BWAY

Watchlist Manager
Brainsway Ltd
TASE:BWAY
Watchlist
Price: 1 746 ILS 2.52%
Market Cap: 573.7m ILS
Have any thoughts about
Brainsway Ltd?
Write Note

Brainsway Ltd
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Brainsway Ltd
Income from Continuing Operations Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
B
Brainsway Ltd
TASE:BWAY
Income from Continuing Operations
-$4.2m
CAGR 3-Years
8%
CAGR 5-Years
8%
CAGR 10-Years
5%
Nano-X Imaging Ltd
NASDAQ:NNOX
Income from Continuing Operations
-$60.8m
CAGR 3-Years
-12%
CAGR 5-Years
-100%
CAGR 10-Years
N/A
Inmode Ltd
NASDAQ:INMD
Income from Continuing Operations
$153.7m
CAGR 3-Years
1%
CAGR 5-Years
30%
CAGR 10-Years
N/A
Sisram Medical Ltd
HKEX:1696
Income from Continuing Operations
$27.3m
CAGR 3-Years
1%
CAGR 5-Years
2%
CAGR 10-Years
N/A
S
Sofwave Medical Ltd
TASE:SOFW
Income from Continuing Operations
-$8.3m
CAGR 3-Years
11%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
E
Epitomee Medical Ltd
TASE:EPIT
Income from Continuing Operations
-$5.7m
CAGR 3-Years
-22%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Brainsway Ltd
Glance View

Market Cap
573.7m ILS
Industry
Health Care

Brainsway Ltd. is a commercial stage medical device company, which focuses on the development and sale of non-invasive neuromodulation products using the proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder (MDD) and obsessive-compulsive disorder (OCD). The firm primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.

BWAY Intrinsic Value
2 168.35 ILS
Undervaluation 19%
Intrinsic Value
Price
B

See Also

What is Brainsway Ltd's Income from Continuing Operations?
Income from Continuing Operations
-4.2m USD

Based on the financial report for Dec 31, 2023, Brainsway Ltd's Income from Continuing Operations amounts to -4.2m USD.

What is Brainsway Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
5%

Over the last year, the Income from Continuing Operations growth was 69%. The average annual Income from Continuing Operations growth rates for Brainsway Ltd have been 8% over the past three years , 8% over the past five years , and 5% over the past ten years .

Back to Top